Venture Capital Archives - Page 2 of 105

Meet the Man Behind FDA-Approved Bladder Cancer Breakthrough: Dr. Purnanand Sarma and the Journey of INLEXZO™

September 22, 2025

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

September 19, 2025

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

September 17, 2025

THIS WEEK'S STORIES

Apollo Therapeutics Reports Positive Phase 2a Results for Camoteskimab in Atopic Dermatitis

September 16, 2025

BostonGene Named Platinum Winner for AI Research Innovation at 2025 Pinnacle Awards

September 17, 2025

Vertex Secures CASGEVY Reimbursement Agreement in Italy for Beta Thalassemia and Sickle Cell Disease

September 18, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Saisei Ventures Names James Feliciano as Venture Partner

Odyssey Therapeutics Secures $213 Million in Oversubscribed Series D to Advance Autoimmune Pipeline

LightSpun Raises $13M to Streamline Dental Insurance With AI

Boomerang Medical Secures $20 Million Series B to Advance Pivotal Neuromodulation Trial in Ulcerative Colitis

Enveda Secures $150 Million Series D to Reach Unicorn Status, Enrolls First Patient in Lead Trial, and Welcomes Mikael Dolsten to Board

Most Read

Salt AI Secures $10M to Push Contextual AI in Life Sciences

WHOOP Bolsters Exec Team With New Creative and Legal Chiefs

Meet the Man Behind FDA-Approved Bladder Cancer Breakthrough: Dr. Purnanand Sarma and the Journey of INLEXZO™

Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems

EDITOR PICKS

Meet the Man Behind FDA-Approved Bladder Cancer Breakthrough: Dr. Purnanand Sarma and the Journey of INLEXZO™

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

THIS WEEK'S STORIES

Apollo Therapeutics Reports Positive Phase 2a Results for Camoteskimab in Atopic Dermatitis

BostonGene Named Platinum Winner for AI Research Innovation at 2025 Pinnacle Awards

Vertex Secures CASGEVY Reimbursement Agreement in Italy for Beta Thalassemia and Sickle Cell Disease

POPULAR CATEGORY

ABOUT US

FOLLOW US